BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«MediGene AG

Below is an extended MediGene AG research listing. Click here to return to the MediGene AG main Biocorporate entry.

Recent Publications by MediGene AG:

Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry.
Naturally selected T-cell receptors (TCRs) are characterised by low...
6th December, 2007
Avidex Limited (subsidiary of Medigene Ag), 57c Milton Park, Abingdon, Protein Eng Des Sel. 2007 Aug;20(8):397-403. Epub 2007 Jul 20.
DOI Direct Link
Laminar order within Langmuir-Blodgett multilayers from phospholipid and myelin basic protein: a neutron reflectivity study.
Multilayers consisting of negatively charged phospholipid DMPA and myelin...
3rd October, 2007
Medigene Langmuir. 2007 Jul 31;23(16):8491-6. Epub 2007 Jul 6.
DOI Direct Link
Extraction and quantification of the cationic lipid 1,2-dioleoyl-3-trimethylammonium propane from human plasma.
Multilayers consisting of negatively charged phospholipid DMPA and myelin...
26th May, 2007
MediGene AG, 82152 Martinsried, Germany. Anal Biochem. 2007 Apr 1;363(1):157-9. Epub 2007 Jan 26.
DOI Direct Link
Emerging therapeutic targets in chronic heart failure: part II.
Chronic heart failure is characterised by functional deficiencies of the...
2nd May, 2006
Department of Research, MediGene AG, Martinsried, Germany. Expert Opin Ther Targets. 2003 Feb;7(1):49-59.
DOI Direct Link
A new therapeutic approach to treat psoriasis by inhibition of fatty acid oxidation by Etomoxir.
BACKGROUND: The dogma in psoriasis is that due to pathogen-induced...
4th February, 2006
Medigene AG, Lochhamerstrasse 11, 82152 Martinsried, Germany. Br J Dermatol. 2005 Nov;153(5):937-44.
DOI Direct Link
Emerging therapeutic targets in chronic heart failure: part I.
Chronic heart failure (CHF) is a life threatening disease with an enormous...
27th August, 2005
MediGene AG, Lochhamer Str. 11, 82152 Martinsried, Germany. Expert Opin Ther Targets. 2002 Dec;6(6):649-58.
DOI Direct Link
[ Development of new taxane formulations]
The annual European Society of Cardiology XXIII Congress was an...
30th April, 2005
Pharm Unserer Zeit. 2005;34(2):115-21.
DOI Direct Link
Validation of targets and drug candidates in an engineered three-dimensional cardiac tissue model.
High-throughput target discovery confronts the biopharmaceutical industry...
25th February, 2003
Department of Research, MediGene AG, Lochhamer Str. 11, 82152 Martinsried, Drug Discov Today. 2002 Apr 1;7(7):419-25.
Chimeric virus-like particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and therapeutic vaccine.
Infection by certain human papillomaviruses (HPV), most notably HPV types...
11th March, 2000
MediGene AG, Martinsried, Germany. Arch Med Res. 1999 Jul-Aug;30(4):269-74.

«MediGene AG

This page contained an extended MediGene AG research listing. Click here to return to the MediGene AG main Biocorporate entry.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.